Brain cannabinoid CB2 receptors modulate cocaine's actions in mice

Xi, Zheng-Xiong, Peng, Xiao-Qing, Li, Xia, Song, Rui, Zhang, Hai-Ying, Liu, Qing-Rong, Yang, Hong-Ju, Bi, Guo-Hua, Li, Jie, Gardner, Eliot L·2011·Nature Neuroscience

DOI 10.1038/nn.2874

Cited by (401)

Items 201–300 of 401

Impact of the Cannabinoid System in Alzheimer's Disease
Shuangtao Li, Yuanbing Huang, Lijun Yu, Xiaoyu Ji, Jie Wu · 2022 · Current Neuropharmacology
Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge
Omar Soler‐Cedeño, Zheng‐Xiong Xi · 2022 · Cells
Characterization of cannabinoid receptor ligands in tissues natively expressing cannabinoid CB2 receptors
Pietro Marini, Maria Grazia Cascio, A.W.T. King, Roger G. Pertwee, Ruth A. Ross · 2013 · British Journal of Pharmacology
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders
Vishnudutt Purohit, Rao S. Rapaka, Joni L. Rutter · 2014 · Journal of Neuroimmune Pharmacology
The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice
Marta Kruk-Słomka, Izabela Banaszkiewicz, Grażyna Biała · 2017 · Neurotoxicity Research
Computational Systems Pharmacology-Target Mapping for Fentanyl-Laced Cocaine Overdose
Jin Cheng, Siyi Wang, Weiwei Lin, Nan Wu, Yuanqiang Wang, Maozi Chen, Xiang‐Qun Xie, Zhiwei Feng · 2019 · ACS Chemical Neuroscience
Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects
Qing‐Rong Liu, Ana Canseco-Alba, Ying Liang, Hiroki Ishiguro, Emmanuel Shan Onaivi · 2020 · International Journal of Molecular Sciences
The Role of the Endocannabinoid System in Binge Eating Disorder
Romain Bourdy, Katia Befort · 2023 · International Journal of Molecular Sciences
Neuroinflammation in the Central Nervous System: Exploring the Evolving Influence of Endocannabinoid System
Sumit Rathod, Yogeeta O. Agrawal, Kartik Tularam Nakhate, Mohamed Fizur Nagoor Meeran, Shreesh Kumar Ojha, Sameer N. Goyal · 2023 · Biomedicines
Endocannabinoids as Therapeutic Targets
Oscar E. Prospero-Garcia, Alejandra E. Ruiz‐Contreras, Alette Ortega-Gómez, Andrea Herrera-Solís, Mónica Méndez‐Díaz · 2019 · Archives of Medical Research
Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute d-amphetamine
Alexia Polissidis, Olga Chouliara, Andreas Galanopoulos, George Naxakis, Demetris P. Papahatjis, Zeta Papadopoulou‐Daifoti, Katerina Antoniou · 2014 · Behavioural Brain Research
Δ9-Tetrahydrocannabinol discrimination: Effects of route of administration in rats
Jenny L. Wiley, Shanequa I. Taylor, Julie A. Marusich · 2021 · Drug and Alcohol Dependence
Endocannabinoid Modulation of Nucleus Accumbens Microcircuitry and Terminal Dopamine Release
Dan P. Covey, Alyssa G. Yocky · 2021 · Frontiers in Synaptic Neuroscience
CB2 Receptor Involvement in the Treatment of Substance Use Disorders
Francisco Navarrete, María S. García‐Gutiérrez, Ani Gasparyan, Daniela Navarro, Jorge Manzanares · 2021 · Biomolecules
Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward‐Related Behaviors
Matthew S. Powers, Kristen R. Breit, Julia A. Chester · 2015 · Alcoholism Clinical and Experimental Research
Alcohol-induced conditioned place preference is modulated by CB2 cannabinoid receptors and modifies levels of endocannabinoids in the mesocorticolimbic system
Ana Martín‐Sánchez, Vincent Warnault, Sandra Montagud‐Romero, Antoni Pastor, Neus Mondragón, Rafael de la Torre, Olga Valverde · 2019 · Pharmacology Biochemistry and Behavior
Cannabinoids and Cardiovascular System
Alexander I. Bondarenko · 2019 · Advances in experimental medicine and biology
Endocannabinoid modulation of dopamine release during reward seeking, interval timing, and avoidance
Thomas J. Everett, Devan M. Gomez, Lindsey R. Hamilton, Erik B. Oleson · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area
Hong Zhang, Austin A. Lipinski, Erika Liktor‐Busa, Angela F. Smith, Aubin Moutal, Rajesh Khanna, Paul R. Langlais, Tally M. Largent‐Milnes, Todd W. Vanderah · 2021 · Frontiers in Pharmacology
Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
Tapio Nevalainen · 2013 · Current Medicinal Chemistry
Endocannabinoid-Dependent Modulation of Phasic Dopamine Signaling Encodes External and Internal Reward-Predictive Cues
Jennifer M. Wenzel, Joseph F. Cheer · 2014 · Frontiers in Psychiatry
An Overview of Major and Minor Phytocannabinoids
Jahan P. Marcu · 2016 · Elsevier eBooks
In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI
R. Ni, Adrienne Müller Herde, A. Haider, Claudia Keller, G. Louloudis, M. Vaas, R. Schibli, S. Ametamey, J. Klohs, L. Mu · 2021 · bioRxiv
Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration
Pál Pacher, Ken Mackie · 2012 · Journal of Molecular Medicine
Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic rats
J Gao, Chloe J. Jordan, Guo‐Hua Bi, Yi He, Hong-Ju Yang, Eliot L. Gardner, Zheng‐Xiong Xi · 2018 · Neuropsychopharmacology
D2 autoreceptor switches CB2 receptor effects on [3H]‐dopamine release in the striatum
Gabriel López‐Ramírez, Rodolfo Sánchez‐Zavaleta, Arturo Ávalos‐Fuentes, Juan José Sierra, Francisco Javier Paz‐Bermúdez, Gerardo Leyva‐Gómez, José Segovia‐Vila, Hernán Cortés, Benjamín Florán · 2019 · Synapse
Chemogenomics knowledgebased polypharmacology analyses of drug abuse related G-protein coupled receptors and their ligands
Xiang‐Qun Xie, Lirong Wang, Haibin Liu, Qin Ouyang, Cheng Fang, Weiwei Su · 2014 · Frontiers in Pharmacology
Cannabinoids in Health and Disease
Rosaria Meccariello, Rosanna Chianese · 2016 · InTech eBooks
Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain
Panagiotis Perdikaris, Martha Tsarouchi, Εleni Fanarioti, Evangelos Natsaridis, Ada Mitsacos, Panagiotis Giompres · 2017 · Neuropharmacology
Repeated cocaine administration upregulates CB2 receptor expression in striatal medium-spiny neurons that express dopamine D1 receptors in mice
Hai‐Ying Zhang, Lindsay M. De Biase, Ramesh Chandra, Hui Shen, Qing‐Rong Liu, Eliot L. Gardner, Mary Kay Lobo, Zheng‐Xiong Xi · 2021 · Acta Pharmacologica Sinica
The CB2 Receptor as a Novel Therapeutic Target for Epilepsy Treatment
Xiaoyu Ji, Yang Zeng, Jie Wu · 2021 · International Journal of Molecular Sciences
DeepREAL: a deep learning powered multi-scale modeling framework for predicting out-of-distribution ligand-induced GPCR activity
Tian Cai, Kyra Alyssa Abbu, Yang Liu, Lei Xie · 2022 · Bioinformatics
Lipids and addiction: how sex steroids, prostaglandins, and cannabinoids interact with drugs of abuse
Emma Leishman, Kevin J. Kokesh, Heather B. Bradshaw · 2013 · Annals of the New York Academy of Sciences
Trisubstituted Sulfonamides: A New Chemotype for Development of Potent and Selective CB2Receptor Inverse Agonists
Qin Ouyang, Qin Tong, Rentian Feng, Kyaw-Zeyar Myint, Peng Yang, Xiang‐Qun Xie · 2013 · ACS Medicinal Chemistry Letters
Global fold of human cannabinoid type 2 receptor probed by solid‐state 13C‐, 15N‐MAS NMR and molecular dynamics simulations
Tomohiro Kimura, Krishna Vukoti, Diane L. Lynch, Dow P. Hurst, Alan M. Grossfield, Michael C. Pitman, Patricia H. Reggio, Alexei Yeliseev, Klaus Gawrisch · 2013 · Proteins Structure Function and Bioinformatics
Targeted zwitterionic near infrared fluorescent probe for improved imaging of type 2 cannabinoid receptors
Zhiyuan Wu, Pin Shao, Shaojuan Zhang, Mingfeng Bai · 2014 · Journal of Biomedical Optics
Effects of acute and repeated dosing of the synthetic cannabinoid CP55,940 on intracranial self-stimulation in mice
Travis W. Grim, Jason M. Wiebelhaus, Anthony J. Morales, Sidney Stevens Negus, Aron H. Lichtman · 2015 · Drug and Alcohol Dependence
Δ8‐Tetrahydrocannabivarin has potent anti‐nicotine effects in several rodent models of nicotine dependence
Zheng‐Xiong Xi, Pretal P. Muldoon, Xiao‐Fei Wang, Guo‐Hua Bi, Mohamad Imad Damaj, Aron H. Lichtman, Roger G. Pertwee, Eliot L. Gardner · 2019 · British Journal of Pharmacology
A role for the endocannabinoid enzymes monoacylglycerol and diacylglycerol lipases in cue‐induced cocaine craving following prolonged abstinence
Swarup Mitra, Pedro Henrique Gobira, Craig T. Werner, Jennifer A. Martin, Madoka Iida, Shruthi A. Thomas, Kyra Erias, Sophia A. Miracle, Charles Lafargue, Chunna An et al. · 2021 · Addiction Biology
Endocannabinoid system and drug addiction: new insights from mutant mice approaches
Rafael J. Maldonado, Patricia Robledo, Fernando Berrendero · 2013 · Current Opinion in Neurobiology
T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice
Xiao-Fei Wang, Elisabeth Barbier, Yi-Ting Chiu, Yi He, Jia Zhan, Guo‐Hua Bi, Hai‐Ying Zhang, Bo Feng, Lee‐Yuan Liu‐Chen, Jia Bei Wang et al. · 2016 · Journal of Neuroscience
Xie2-64, a novel CB2 receptor inverse agonist, reduces cocaine abuse-related behaviors in rodents
Chloe J. Jordan, Zhiwei Feng, Ewa Galaj, Guo‐Hua Bi, Ying Xue, Ying Liang, Terence Francis McGuire, Xiang‐Qun Xie, Zheng‐Xiong Xi · 2020 · Neuropharmacology
Cannabinoid CB2 receptor orthologues; in vitro function and perspectives for preclinical to clinical translation
Emma R. Carruthers, Natasha Lillia Grimsey · 2023 · British Journal of Pharmacology
Khat (Catha edulis F.) and cannabinoids: Parallel and contrasting behavioral effects in preclinical and clinical studies
Berhanu Geresu Kibret · 2015 · Pharmacology Biochemistry and Behavior
Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks
Thércia Guedes Viana, Juliana dos Reis Bastos, Rayssa C. Briânis, Sara Cristina Hott, Frederico Sander Mansur Machado, Cândido Celso Coimbra, Leonardo B.M. Resstel, Daniele Cristina de Aguiar, Fabrício A. Moreira · 2019 · Neuropharmacology
Altered Swimming Behaviors in Zebrafish Larvae Lacking Cannabinoid Receptor 2
Agnes Acevedo‐Canabal, Luis Colón-Cruz, Roberto Rodríguez‐Morales, Gaurav K. Varshney, Shawn M. Burgess, Lorena González‐Sepúlveda, Guillermo Ariel Yudowski, Martine L. Behra · 2019 · Cannabis and Cannabinoid Research
Endocannabinoid-Binding Receptors as Drug Targets
María Gómez‐Cañas, Carmen Rodríguez‐Cueto, Valentina Satta, Inés Hernández-Fisac, Elisa Navarro, Javier Fernández‐Ruíz · 2022 · Methods in molecular biology
Characterization of the intrinsic activity for a novel class of cannabinoid receptor ligands: Indole quinuclidine analogs
Lirit N. Franks, Benjamin M. Ford, Nikhil Reddy Madadi, Narsimha Reddy Penthala, Peter Anthony Crooks, Paul L. Prather · 2014 · European Journal of Pharmacology
Animal models for opioid addiction drug discovery
Shaness A. Grenald, Tally M. Largent‐Milnes, Todd W. Vanderah · 2014 · Expert Opinion on Drug Discovery
Nucleus accumbens hyperpolarization-activated cyclic nucleotide-gated channels modulate methamphetamine self-administration in rats
Danni Cao, Rui Song, Shuzhuo Zhang, Ning Wu, Jin Li · 2016 · Psychopharmacology
Expression and localization of CB1R, NAPE-PLD, and FAAH in the vervet monkey nucleus accumbens
Ryan Kucera, Joseph Bouskila, Laurent Elkrief, Anders Fink‐Jensen, Roberta M. Palmour, Jean‐François Bouchard, Maurice Ptito · 2018 · Scientific Reports
Cannabinoids affect the mouse visual acuity via the cannabinoid receptor type 2
Bruno Cécyre, Ismaël Bachand, François Papineau, Chloé Brochu, Christian Casanova, Jean‐François Bouchard · 2020 · Scientific Reports
Cannabinoids and Sleep/Wake Control
Mónica Méndez‐Díaz, Alejandra E. Ruiz‐Contreras, Jacqueline Cortés Morelos, Oscar E. Prospero-Garcia · 2021 · Advances in experimental medicine and biology
Marijuana: A systems-based primer of adverse effects associated with use and an overview of its therapeutic utility
Asim Kichloo, Michael Stanley Albosta, Michael M. Aljadah, Zain El‐amir, Ghazaleh Goldar, Muhammed Zatmar Khan, Dushyant Singh Dahiya, Srilakshmi Vallabhaneni, Farah Wani, Jagmeet Singh · 2021 · SAGE Open Medicine
Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes
Qing‐Rong Liu, Kanikkai Raja Aseer, Qin Yao, Xiaoming Zhong, Paritosh Ghosh, Jennifer F. O’Connell, Josephine Mary Egan · 2022 · Frontiers in Pharmacology
Endocannabinoid Signaling in the Striatum
David M. Lovinger, Margaret I. Davis, Rui M. Costa · 2010 · Handbook of behavioral neuroscience
The endocannabinoid‐alcohol crosstalk: Recent advances on a bi‐faceted target
Gianluca Lavanco, Valentina Castelli, Anna Brancato, Giuseppe Tringali, Fulvio Plescia, Carla Cannizzaro · 2018 · Clinical and Experimental Pharmacology and Physiology
A Review on the Bioactivity of Cannabinoids on Zebrafish Models: Emphasis on Neurodevelopment
Rosario Licitra, Maria Marchese, Valentina Naef, Asahi Ogi, Marco Martinelli, Claudia Kiferle, Baldassare Fronte, Filippo Maria Santorelli · 2022 · Biomedicines
Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits
Anthony S. Ferranti, Daniel J. Foster · 2022 · Frontiers in Neuroscience
Role of CB2 cannabinoid receptor in the development of food addiction in male mice
Alejandra García‐Blanco, Angela Ramírez‐López, Francisco Navarrete, María S. García‐Gutiérrez, Jorge Manzanares, Elena Martín‐García, Rafael J. Maldonado · 2023 · Neurobiology of Disease
The cannabinoid CB2 agonist LY2828360 suppresses neuropathic pain behavior and attenuates morphine tolerance and conditioned place preference in rats
Kelsey G. Guenther, Jonah L. Wirt, Idaira Oliva, Shahin A. Saberi, Jonathon D. Crystal, Andrea G. Hohmann · 2024 · Neuropharmacology
HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia
Isadora Lopes Cortez, Nicole Rodrigues da Silva, Naielly S. Rodrigues, João Francisco Cordeiro Pedrazzi, Elaine Aparecida Del Bel, Raphael Mechoulam, Felipe V. Gomes, Francisco Silveira Guimarães · 2022 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Consideration of sex as a biological variable in the translation of pharmacotherapy for stress-associated drug seeking
Erin L. Martin, Elizabeth M. Doncheck, Carmela M. Reichel, Aimee L. McRae‐Clark · 2021 · Neurobiology of Stress
Conditional deletion of CB2 cannabinoid receptors from peripheral sensory neurons eliminates CB2-mediated antinociceptive efficacy in a mouse model of carrageenan-induced inflammatory pain
Kelsey G. Guenther, Zhili Xu, Julián Romero, Cecilia J. Hillard, Ken Mackie, Andrea G. Hohmann · 2023 · Neuropharmacology
Aspergillus sydowii and Typha angustifolia as useful tools for combined bio-processes of PCP removal in wastewater
Rim Werheni Ammeri, Giuseppe Di Rauso Simeone, Wafa Hassen, Marwa Smiri, Najla Sadfi‐Zouaoui, Yassine Hidri, Abdennaceur Hassen · 2022 · International Journal of Environmental Science and Technology
Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies
María S. García‐Gutiérrez, Francisco Navarrete, Ani Gasparyan, Daniela Navarro, Álvaro Morcuende, Teresa Femenía, Jorge Manzanares · 2022 · International Journal of Molecular Sciences
Deletion of VGLUT2 in midbrain dopamine neurons attenuates dopamine and glutamate responses to methamphetamine in mice
Hui Shen, Kai Chen, Rosa Anna Maria Marino, Ross A. McDevitt, Zheng‐Xiong Xi · 2021 · Pharmacology Biochemistry and Behavior
Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders
Ujendra Kumar · 2024 · International Journal of Molecular Sciences
An interrupted Heyns rearrangement approach for the regioselective synthesis of acylindoles
Minakshi Altia, Pazhamalai Anbarasan · 2023 · Chemical Communications
New Insights Into Peptide Cannabinoids: Structure, Biosynthesis and Signaling
Agustín Riquelme-Sandoval, Caio Oliveira de Sá-Ferreira, Leo M. Miyakoshi, Cecilia Hedin‐Pereira · 2020 · Frontiers in Pharmacology
Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases
Hebaallah Mamdouh Hashiesh, Niraj Kumar Jha, Charu Sharma, Piyush Kumar Gupta, Saurabh Kumar Jha, Chandragouda Raosaheb Patil, Sameer N. Goyal, Shreesh Kumar Ojha · 2021 · European Journal of Pharmacology
Behavioral evidence for the interaction between cannabinoids and Catha edulis F. (Khat) in mice
Berhanu Geresu Kibret, Emmanuel Shan Onaivi, Ephrem Engidawork · 2016 · Brain Research
Cannabinoid 2 receptors regulate dopamine 2 receptor expression by a beta-arrestin 2 and GRK5-dependent mechanism in neuronal cells
Jade M. Franklin, Riordan Kennedy Broseguini de Souza, Gonzalo A. Carrasco · 2021 · Neuroscience Letters
Cannabinoid receptor type 2 gene is associated with comorbidity of schizophrenia and cannabis dependence and fatty acid amide hydrolase gene is associated with cannabis dependence in the Spanish population
F. Árias, José Ramón Dávila Píriz, Alba Parra, Sergio Sánchez Romero, Eva María Sánchez‐Morla, Israel Ampuero, José Antonio Ramos Atance · 2021 · Adicciones
Parkinson’s disease related alterations in cannabinoid transmission
Monavareh Soti, Hoda Ranjbar, Kristi A. Kohlmeier, Mohammad Shabani · 2021 · Brain Research Bulletin
The endocannabinoid system and drug-associated contextual memories
Laila Asth, Aline Cunha Santos, Fabrício A. Moreira · 2021 · Behavioural Pharmacology
PET Imaging of Endocannabinoid System
Andrew G. Horti, Vanessa Raymont, Garth E. Terry · 2014 · Springer eBooks
Epigenetic mechanisms associated with addiction-related behavioural effects of nicotine and/or cocaine: implication of the endocannabinoid system
Tamaki Hayase · 2017 · Behavioural Pharmacology
Contribution of CB1Rs in anxiety-related behaviors but not locomotor deficits induced by methamphetamine
Effat Ramshini, Gholamreza Sepehri, Meysam Ahmadi‐Zeidabadi, Shokouh Arjmand, Mohammad Khaksari, Mohammad Shabani · 2017 · Neuroscience Letters
Involvement of CB2 Receptors in the Neurobehavioral Effects of Catha Edulis (Vahl) Endl. (Khat) in Mice
Berhanu Geresu Kibret, Ana Canseco-Alba, Branden Sanabria, Zhicheng Lin, Qing‐Rong Liu, Emmanuel Shan Onaivi, Ephrem Engidawork · 2019 · Molecules
Endocannabinoid-Mediated Neuromodulation in the Olfactory Bulb: Functional and Therapeutic Significance
Naina Bhatia‐Dey, Thomas Heinbockel · 2020 · International Journal of Molecular Sciences
The endocannabinoid system and emotional processing: pathophysiology and therapeutic potential
David P. Finn, María‐Paz Viveros, Eva María Marco · 2012 · Journal of Psychopharmacology
Roles of cannabinoid CB1 and CB2 receptors in the modulation of psychostimulant responses
Pedro Henrique Gobira, Sâmia R.L. Joca, Fabrício A. Moreira · 2022 · Acta Neuropsychiatrica
Patent review of cannabinoid receptor type 2 (CB 2 R) modulators (2016-present)
Miroslav Kosar, Leonard Mach, Erick M. Carreira, Marc Nazaré, Pál Pacher, Uwe Grether · 2024 · Expert Opinion on Therapeutic Patents
Molecular brain differences and cannabis involvement: A systematic review of positron emission tomography studies
Hui Xu, Max M. Owens, Troy H. Farncombe, Michael D. Noseworthy, James M. MacKillop · 2023 · Journal of Psychiatric Research
The Down-Expression of ACE and IDE Exacerbates Exogenous Amyloid-β Neurotoxicity in CB2R–/– Mice
Lin Wang, Fang-Xiao Shi, Weiqi Xu, Yun Cao, Na Li, Man Li, Qun Wang, Jian‐Zhi Wang, Qing Tian, Likai Yu et al. · 2018 · Journal of Alzheimer s Disease
Therapeutic potential of PIMSR, a novel CB1 receptor neutral antagonist, for cocaine use disorder: evidence from preclinical research
Ewa Galaj, Briana J. Hempel, Allamar R. Moore, Benjamin Klein, Guo‐Hua Bi, Eliot L. Gardner, Herbert H. Seltzman, Zheng‐Xiong Xi · 2022 · Translational Psychiatry
Endocannabinoid/GABA interactions in the entopeduncular nucleus modulates alcohol intake in rats
Mónica Méndez‐Díaz, Seraid Caynas-Rojas, David Gómez Armas, Alejandra E. Ruiz‐Contreras, Raúl A. Aguilar‐Roblero, Oscar E. Prospero-Garcia · 2013 · Brain Research Bulletin
Interplay between endocannabinoids and dopamine in the basal ganglia: implications for pain in Parkinson’s disease
Maria Mancini, Alessandra Calculli, Deborah Di Martino, Antonio Pisani · 2024 · Journal of Anesthesia Analgesia and Critical Care
Motor-like Tics are Mediated by CB2 Cannabinoid Receptor-dependent and Independent Mechanisms Associated with Age and Sex
Victoria Gorberg, Veronika Borisov, Iain R. Greig, Roger G. Pertwee, Peter J. A. McCaffery, Sharon Anavi‐Goffer · 2022 · Molecular Neurobiology
Endocannabinoid Receptor 2 Function is Associated with Tumor-Associated Macrophage Accumulation and Increases in T Cell Number to Initiate a Potent Antitumor Response in a Syngeneic Murine Model of Glioblastoma
Jin Duan, Jieling Chen, Yilin Lin, Stanley Li Lin, Jie Wu · 2024 · Cannabis and Cannabinoid Research
Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors
Shayma El-Atawneh, Amiram Goldblum · 2022 · Frontiers in Pharmacology
Impact of Stress on Prefrontal Glutamatergic, Monoaminergic and Cannabinoid Systems
M. Danet Lapiz Bluhm · 2014 · Current topics in behavioral neurosciences
The CB2 Receptor in Immune Regulation and Disease: Genetic Architecture, Epigenetic Control, and Emerging Therapeutic Strategies
Hilal Kalkan, Nicolas Flamand · 2025 · DNA
Endocannabinoid system as a therapeutic target for psychostimulants relapse: A systematic review of preclinical studies
Saeideh Karimi‐Haghighi, Maedeh Mahmoudi, Fatemeh Sayehmiri, Roghayeh Mozafari, Abbas Haghparast · 2023 · European Journal of Pharmacology
High hopes for CB2 receptors in neurogenesis
Eric J. Downer · 2013 · British Journal of Pharmacology
The effects of fatty acid amide hydrolase inhibition and monoacylglycerol lipase inhibition on habit formation in mice
Carol A. Gianessi, Stephanie Mary Groman, Jane R. Taylor · 2021 · European Journal of Neuroscience
Therapeutic potential of the cannabinoid receptor 2 in neuropsychiatry
María S. García‐Gutiérrez, Francisco Navarrete, Ani Gasparyan, Jorge Manzanares · 2021 · Exploration of Neuroprotective Therapy
Brain CB2 receptor: a new target in medication development for treating opioid use disorder in rodents
Omar Soler‐Cedeño, Hai‐Ying Zhang, Emma Xiong, Guo‐Hua Bi, Hannah Alton, Maia Maras, Qing‐Rong Liu, Pinaki Bhattacharjee, Malliga R. Iyer, Zheng‐Xiong Xi · 2025 · Molecular Psychiatry
Overlapping pathways of migraine and the endocannabinoid system: Potential therapeutic targets
Adriana Della Pietra, Andrew F. Russo · 2026 · Neurotherapeutics